2 June 2021
At the meeting of 5 May 2021 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
asbestosis | 59/2021 | 60/2021 |
gastro-oesophageal reflux disease | 61/2021 | 62/2021 |
IgA nephropathy | 63/2021 | 64/2021 |
malignant neoplasm of the oral cavity, oropharynx and hypopharynx | 65/2021 | 66/2021 |
pes planus | 67/2021 | 68/2021 |
porphyria cutanea tarda | 69/2021 | 70/2021 |
Note: The investigation concerning 'mesangial IgA glomerulonephritis' has resulted in the determination of Statements of Principles concerning IgA nephropathy.
Determined New Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
transverse myelitis | 71/2021 | 72/2021 |
hypogonadism | 73/2021 | 74/2021 |
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
non-Hodgkin lymphoma | 75/2021 | 76/2021 |
The above SOPs take effect from 21 June 2021.
Summary of Changes
Completed Investigations
The above determinations conclude the previously advertised investigations into:
- asbestosis
- gastro-oesophageal reflux disease
- mesangial IgA glomerulonephritis
- malignant neoplasm of the oral cavity, oropharynx and hypopharynx
- pes planus
- porphyria cutanea tarda
- transverse myelitis
- hypogonadism
- non-Hodgkin lymphoma (focussed review - infection with Epstein-Barr virus)
New Investigations
Decided to advertise the following investigations:
- malignant neoplasm of the prostate (focussed review - asbestos exposure)
- malignant neoplasm of the brain (focussed review - exposure to carbamate insecticides and fungicides)
- ischaemic heart disease (focussed review - psoriasis and psoriatic arthritis)
The above investigation notices appear in the Government Notices Gazette of 1 June 2021.